Therefore, the potential effect of ACE2 inhibitor on RAS should be evaluated, and the level of plasma Ang II level should be determined to prevent the adverse drug reaction related to lung injury, and cardiovascular and kidney disease. The gene discussed is ACE2; the disease is kidney disorder.